Anti-Obesity Therapeutics Market Size, Trends, Analysis, and Outlook By Treatment (Medications, Treatments), By End-User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics), by Region, Country, Segment, and Companies, 2024-2030
The global Anti-Obesity Therapeutics market size is poised to register 11.39% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Anti-Obesity Therapeutics market across By Treatment (Medications, Treatments), By End-User (Ambulatory Surgical Centers, Hospitals, Specialty Clinics).
The Anti-Obesity Therapeutics Market is characterized by significant research efforts, therapeutic innovation, and personalized treatment approaches aimed at addressing the global obesity epidemic and its associated comorbidities. Obesity is a complex metabolic disorder influenced by genetic, environmental, and behavioral factors, necessitating a multifaceted approach to weight management and obesity treatment. Key trends include the development of pharmacological agents, bariatric surgery techniques, and lifestyle interventions targeting appetite regulation, energy metabolism, and fat storage mechanisms implicated in obesity pathogenesis. Additionally, there is a growing emphasis on precision medicine strategies, including genetic profiling, gut microbiome analysis, and personalized diet and exercise plans, to tailor obesity treatment and weight loss interventions based on individual patient characteristics, metabolic phenotypes, and treatment responses. Moreover, collaborative research consortia, public health initiatives, and regulatory policies are essential for promoting evidence-based obesity management, reducing stigma, and fostering a supportive environment for healthy lifestyles and sustainable weight loss strategies across diverse populations and healthcare settings.
Anti-Obesity Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Anti-Obesity Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Anti-Obesity Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Anti-Obesity Therapeutics industry.
Key market trends defining the global Anti-Obesity Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Anti-Obesity Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Anti-Obesity Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Anti-Obesity Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Anti-Obesity Therapeutics industry
Leading Anti-Obesity Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Anti-Obesity Therapeutics companies.
Anti-Obesity Therapeutics Market Study- Strategic Analysis Review
The Anti-Obesity Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Anti-Obesity Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Anti-Obesity Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Anti-Obesity Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Anti-Obesity Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Anti-Obesity Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Anti-Obesity Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Anti-Obesity Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Anti-Obesity Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Anti-Obesity Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Anti-Obesity Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Anti-Obesity Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Anti-Obesity Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Anti-Obesity Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Anti-Obesity Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Anti-Obesity Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Anti-Obesity Therapeutics.
Anti-Obesity Therapeutics Market Company Profiles
The global Anti-Obesity Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Currax Pharmaceuticals LLC, Eisai Co. Ltd, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Merck & Co. Inc, Norgine B.V., Novartis AG, Novo Nordisk A/S, Pfizer Inc, Rhythm Pharmaceuticals Inc, SHIONOGI & Co. Ltd, Takeda Pharmaceutical Company Ltd, Vivus LLC
Recent Anti-Obesity Therapeutics Market Developments
The global Anti-Obesity Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Anti-Obesity Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Treatment
Medications
Treatments
By End-user
Ambulatory Surgical Centers
Hospitals
Specialty Clinics
Geographical Segmentation:
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Currax Pharmaceuticals LLC
Eisai Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc
Norgine B.V.
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Rhythm Pharmaceuticals Inc
SHIONOGI & Co. Ltd
Takeda Pharmaceutical Company Ltd
Vivus LLC
Formats Available: Excel, PDF, and PPT
The Anti-Obesity Therapeutics Market is characterized by significant research efforts, therapeutic innovation, and personalized treatment approaches aimed at addressing the global obesity epidemic and its associated comorbidities. Obesity is a complex metabolic disorder influenced by genetic, environmental, and behavioral factors, necessitating a multifaceted approach to weight management and obesity treatment. Key trends include the development of pharmacological agents, bariatric surgery techniques, and lifestyle interventions targeting appetite regulation, energy metabolism, and fat storage mechanisms implicated in obesity pathogenesis. Additionally, there is a growing emphasis on precision medicine strategies, including genetic profiling, gut microbiome analysis, and personalized diet and exercise plans, to tailor obesity treatment and weight loss interventions based on individual patient characteristics, metabolic phenotypes, and treatment responses. Moreover, collaborative research consortia, public health initiatives, and regulatory policies are essential for promoting evidence-based obesity management, reducing stigma, and fostering a supportive environment for healthy lifestyles and sustainable weight loss strategies across diverse populations and healthcare settings.
Anti-Obesity Therapeutics Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Anti-Obesity Therapeutics market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Anti-Obesity Therapeutics survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Anti-Obesity Therapeutics industry.
Key market trends defining the global Anti-Obesity Therapeutics demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Anti-Obesity Therapeutics Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Anti-Obesity Therapeutics industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Anti-Obesity Therapeutics companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Anti-Obesity Therapeutics industry
Leading Anti-Obesity Therapeutics companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Anti-Obesity Therapeutics companies.
Anti-Obesity Therapeutics Market Study- Strategic Analysis Review
The Anti-Obesity Therapeutics market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Anti-Obesity Therapeutics industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Anti-Obesity Therapeutics Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Anti-Obesity Therapeutics Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Anti-Obesity Therapeutics market segments. Similarly, Strong end-user demand is encouraging Canadian Anti-Obesity Therapeutics companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Anti-Obesity Therapeutics market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Anti-Obesity Therapeutics Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Anti-Obesity Therapeutics industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Anti-Obesity Therapeutics market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Anti-Obesity Therapeutics Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Anti-Obesity Therapeutics in Asia Pacific. In particular, China, India, and South East Asian Anti-Obesity Therapeutics markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Anti-Obesity Therapeutics Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Anti-Obesity Therapeutics Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Anti-Obesity Therapeutics market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Anti-Obesity Therapeutics.
Anti-Obesity Therapeutics Market Company Profiles
The global Anti-Obesity Therapeutics market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Currax Pharmaceuticals LLC, Eisai Co. Ltd, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Merck & Co. Inc, Norgine B.V., Novartis AG, Novo Nordisk A/S, Pfizer Inc, Rhythm Pharmaceuticals Inc, SHIONOGI & Co. Ltd, Takeda Pharmaceutical Company Ltd, Vivus LLC
Recent Anti-Obesity Therapeutics Market Developments
The global Anti-Obesity Therapeutics market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Anti-Obesity Therapeutics Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Treatment
Medications
Treatments
By End-user
Ambulatory Surgical Centers
Hospitals
Specialty Clinics
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Currax Pharmaceuticals LLC
Eisai Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc
Norgine B.V.
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Rhythm Pharmaceuticals Inc
SHIONOGI & Co. Ltd
Takeda Pharmaceutical Company Ltd
Vivus LLC
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Anti-Obesity Therapeutics Market Overview and Key Findings, 2024
1.2 Anti-Obesity Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Anti-Obesity Therapeutics Market Growth Opportunities to 2030
1.4 Key Anti-Obesity Therapeutics Market Trends and Challenges
1.4.1 Anti-Obesity Therapeutics Market Drivers and Trends
1.4.2 Anti-Obesity Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Anti-Obesity Therapeutics Companies
2. ANTI-OBESITY THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Anti-Obesity Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Anti-Obesity Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANTI-OBESITY THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment
Medications
Treatments
By End-user
Ambulatory Surgical Centers
Hospitals
Specialty Clinics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Anti-Obesity Therapeutics Market, 2025
5.2 Asia Pacific Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Anti-Obesity Therapeutics Market, 2025
5.5 Europe Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Anti-Obesity Therapeutics Market, 2025
5.8 North America Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Anti-Obesity Therapeutics Market, 2025
5.11 South America Pacific Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Anti-Obesity Therapeutics Market, 2025
5.14 Middle East Africa Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Anti-Obesity Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Anti-Obesity Therapeutics Industry Drivers and Opportunities
7. ANTI-OBESITY THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANTI-OBESITY THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Anti-Obesity Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Currax Pharmaceuticals LLC
Eisai Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc
Norgine B.V.
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Rhythm Pharmaceuticals Inc
SHIONOGI & Co. Ltd
Takeda Pharmaceutical Company Ltd
Vivus LLC
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Anti-Obesity Therapeutics Market Overview and Key Findings, 2024
1.2 Anti-Obesity Therapeutics Market Size and Growth Outlook, 2021- 2030
1.3 Anti-Obesity Therapeutics Market Growth Opportunities to 2030
1.4 Key Anti-Obesity Therapeutics Market Trends and Challenges
1.4.1 Anti-Obesity Therapeutics Market Drivers and Trends
1.4.2 Anti-Obesity Therapeutics Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Anti-Obesity Therapeutics Companies
2. ANTI-OBESITY THERAPEUTICS MARKET SIZE OUTLOOK TO 2030
2.1 Anti-Obesity Therapeutics Market Size Outlook, USD Million, 2021- 2030
2.2 Anti-Obesity Therapeutics Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ANTI-OBESITY THERAPEUTICS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment
Medications
Treatments
By End-user
Ambulatory Surgical Centers
Hospitals
Specialty Clinics
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Anti-Obesity Therapeutics Market, 2025
5.2 Asia Pacific Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Anti-Obesity Therapeutics Market, 2025
5.5 Europe Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.6 Europe Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Anti-Obesity Therapeutics Market, 2025
5.8 North America Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.9 North America Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Anti-Obesity Therapeutics Market, 2025
5.11 South America Pacific Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.12 South America Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Anti-Obesity Therapeutics Market, 2025
5.14 Middle East Africa Anti-Obesity Therapeutics Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Anti-Obesity Therapeutics Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Anti-Obesity Therapeutics Market Size Outlook and Revenue Growth Forecasts
6.2 US Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Anti-Obesity Therapeutics Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Anti-Obesity Therapeutics Industry Drivers and Opportunities
7. ANTI-OBESITY THERAPEUTICS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ANTI-OBESITY THERAPEUTICS COMPANY PROFILES
8.1 Profiles of Leading Anti-Obesity Therapeutics Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Currax Pharmaceuticals LLC
Eisai Co. Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc
Norgine B.V.
Novartis AG
Novo Nordisk A/S
Pfizer Inc
Rhythm Pharmaceuticals Inc
SHIONOGI & Co. Ltd
Takeda Pharmaceutical Company Ltd
Vivus LLC
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
